|

Efgartigimod Clinical Trials

5 actively recruiting trials across 3 locations

Other2 trials

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod
Phase 4
Seronegative Myasthenia Gravis - Efgartigimod IV
Phase 3

San Francisco, California1 trial

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

UCSF Medical Center - Helen Diller Family Comprehensive Cancer Center - Brain Tumor Center,

Boca Raton, Florida1 trial

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

SFM Clinical Research LLC

Phase 3

Morgantown, West Virginia1 trial

A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.

United BioSource LLC

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.